Browse Category: Cancer Research

The Types Of Positions Cancer Treatment Centers Of America Offers Professionals

Cancer Treatment Centers of America hires for a wide variety of positions at their member hospitals. They need people that are skilled in the field of medicine as well as accountants, janitorial services, customer service, food handlers, and more. They pay a competitive rate for these occupations in relation to what competitors offer in each of the markets in which CTCA operates.
CTCA has been certified as one of the 150 “great places to work in healthcare” as well as the 2nd healthiest place to work among mid-sized companies. The invest in their employees by supporting their ongoing education that keeps them current with the latest advances in their profession. Physicians who join CTA get an opportunity to work in a collaborative environment that uses evidence-based medicine to treat their patients. CTCA looks for nurses who can consistently deliver compassionate care to their patients and who can produce superior results.

Cancer Treatment Centers of America has entry-level positions so that those fresh out of college have an opportunity to start their professional career. They also offer fellowships and internships as well. They have a summer intern program for college students that takes place over 10 to 12 weeks. Each intern is guided by an Internship Sponsor. They are included in team meetings and help complete the initiatives of the department they were placed in. They also receive feedback throughout the internship with a final feedback session as the internship winds down.

CTCA was established in 1988. They take a personalized approach to cancer care that is focused on the individual patient. They handle everything in-house such as precision cancer treatment and assessing tumors on a genomic level. They have the most cutting-edge of technology in their hospitals that is used by medical professionals who have received advanced training in their use. They also support their patients as they deal with the side-effects of cancer therapy such as nausea, profound tiredness, depression, lack of appetite, as well as others.

The oncologists at Cancer Treatment Centers of America includes specialists in all forms of cancer such as colorectal, breast, throat, lung, ovarian, pancreatic, prostate, and more. The oncologists that work for this organization are board-certified and have advanced degrees in their medical field of expertise. As cancer is a complex disease, CTCA has coordinated care so that the whole patient is treated effectively. It can be a complicated journey to go through for patients such as keeping track of doctors appointments, refilling their prescriptions, collecting their personal medical records, filing for disability, and everything else that goes into dealing with this disease. This is why CTCA assigns a personal care manager to each patient that will provide whatever support the patient needs as they deal with this disease.

To Read More Click Here

How Dr. Clay Siegall Shaped Seattle Genetics

Cancer is one of leading killers worldwide. One doctor has innovated genetic treatment to help give hope to those with the most serious types of cancer. That doctor, Dr. Clay Siegall, has shaped his Seattle Genetics to become one of the leading cancer therapy companies in the world.

In a recent interview, Dr. Siegall discussed his innovative approach to cancer treatment. And how his business skills helped make Seattle Genetics one of the premier cancer treatment companies in the country. When asked about the origins of Seattle Genetics, Dr. Siegall mentioned the ordeal one of his family members went through during cancer treatment. After seeing this family member nearly die from the side effects of the treatment, Dr. Siegall sought to find a more effective way to treat cancer patients.

Seattle Genetics was founded in 1998 and for over two decades have helped thousands of patients through the use of targeted gene therapy. When discussing the financial side of the business, Dr. Siegall mentioned that one of the profit centers for the company is the selling of a proprietary drug. The drug was the first antibody-drug conjugate ever approved by the Food and Drug Administration. Additionally, when asked about how long it took for Seattle Genetics to become profitable, Dr. Siegall mentioned that it took about ten years.

When also asked about the challenging times at Seattle Genetics, Dr. Siegall mentioned that there were some moments during the first and the second year of the company that their cash was close to being depleted. However, due to Dr. Siegall’s persistence, as well as the hard work of the research staff, Seattle Genetics was able to survive and grow for the next two decades.

Dr. Clay Siegall was educated at the University of Maryland where he received a Bachelor of Science degree in Zoology. Later, Dr. Siegall would receive a Doctorate in Genetics from George Washington University. Today Dr. Siegall is a leading authority on genetic cancer treatments whose Seattle Genetics is helping innovate the world of cancer therapy.

Dr. Jennifer Walden, Mom, Doctor, Free Thinker And More.

Anyone who knows anything about Texas and has been researching plastic surgeons might already know a small truck load of information about Dr. Jennifer Walden. For example, she is one of a few female doctors who is a board certified plastic surgeon. She was trained in Texas and currently has her practice there. Dr. Walden founded MedSpa Walden Cosmetic Surgery and Laser Center. In that center she can do many wonderful things. Surgeries of the facical area, breast area, nose, genitals and anywhere on the body. Dr. Walden can even make many improvements on work that has already been done. She has a unique approach to her line of work, she treats the whole patient.There is so much more about Dr. Jennifer Walden than just doing here daily duty as a highly skilled plastic surgeon. As a doctor she does all the lifts and tucks and improvement work that her clients come to expect from her.

In addition to that she teaches other doctors to perform surgeries and writes articles for trade publications. There is no question that Dr. Jennifer Walden is a successful doctor, but, she is so much more.Dr. Walden’s private life is exciting and an inspiration to many. She is a mother of twin boys. Houston and Rex are her boys. These boys were brought into the world by using IVF and an anonymous donor. Dr. Walden calls the boys her greatest blessing. The doctor’s civic engagements are also many. As she lives a balanced life, Dr. Walden keeps up with charitable support. Se has been named a runner up by the Austin Leukemia and Lymphoma Society for Austin’s Woman of the Year. She’s a Guardian Angel Society member and brings awareness to heart disease as an Executive Leadership Team member for the American Heart Association.Dr. Walden is a native of Austin Texas and she wants to raise her boys in Austin. Being close to family and doing as much as she can in the city is something she is very proud of. One thing you might not know about Austin is that the city is very happy to support woman owned business and that is great for both the city and the people of Austin.

The Rising Costs of Healthcare and Ways Eric Lefkofsky’s Tempus can Keep the Costs Down

Eric Lefkofsky’s company Tempus is a technology company the hosts a medical library that stores clinical data. Naturally, they would also be very aware of the increasing costs of medical care. Recently, Forbes released an article in the Pharma and Healthcare section that dealt with the skyrocketing cost of healthcare.

The cost of healthcare expenditure in America keep rising, which is causing many to wonder why. Is it the number of visits to medical professionals that are increasing consequently affecting the overall expenditure for healthcare? Is it the length of time under the care of medical professionals? The answer is no to both questions. The reason healthcare costs keep rising is due to the increased costs associated with every type of care.

Stays in the hospital, though shorter cost more. Medical procedures though more advanced and sometimes utilizing a robot instead of a board certified surgeon cost more. The diseases or disorders that had the greatest increase in spending were diabetes and back and neck pain. The cost of treating people who suffered from diabetes increased because of the aging population, the increase of the number of people suffering disease and the increased use of pharmaceuticals. The number of back and neck pain sufferers decreased, therefore they sought less medical attention as a whole, but the remaining patients got more medical procedures performed, so the cost went up.

Despite efforts to reduce the length of time spent on inpatient care, while the costs were reduced by 201 billion, they were counterbalanced by more care being given in less time so the result was an overall increase in spending of $439 billion. In fact, one day in the hospital costs far more than it ever has. The director of the Division of Health Policy Research and Education at Harvard stated that he couldn’t determine if increased costs of healthcare represented increased value given to the patients.

Eric Lefkofsky and Tempus are working hard to compile a molecular library composed of medical data from thousands of individual cancer patients. With all that data, the costs of many cancer fighting methods will be less when the fight is focused on a single treatment that has been proven to work on similar cases. Tempus may single-handedly help keep the costs of medical care down in the near future.

For More Info : www.tempus.com/about-us/

Exploring The Contribution of Clay Siegall To Cancer Research

 

Research aimed at delivering new ways of treating cancer has been on for many years. In the past decade, many companies in the pharmaceutical industry have pumped more funds and energy into cancer research and their objective has been to come up with a reliable technology that can make cancer treatment easier and more successful. Among these companies is Seattle Genetics, a company that has proved to offer modern solutions to the development of the industry. Seattle Genetics has been funding and pursuing research to unveil new treatment methods for cancer.

Under the leadership of Clay Siegall, who also co-founded the company, Seattle Genetics has managed to release different drug pipelines like ADCETRIS, which has recorded a lot of success across the world. Most importantly, Seattle Genetics developed the ADC Technology, whose focus is discriminating cells while treating cancer to ensure only infected cells are eliminated.

The traditional radiation method of killing cancer cells does not effectively achieve this as it also kills cells that are healthy, thereby weakening the patient further. ADC will ensure patients are not exposed to the risk of losing healthy cells while receiving treatment. Seattle Genetics has also been able to invite other companies to support the development of superior drug pipelines and technologies that could help them to achieve a milestone in cancer treatment.

About Clay Siegall

Clay B. Siegall, the founder, CEO and President of Seattle Genetics, is a clinical scientist, whose passion in medicine has motivated him to invest more into cancer research and the development of treatment options that are geared towards enhancing treatment practices. His company has been sponsoring research in this field and over the past 10 years, they unveiled several products, among them the ADC Technology, which allows for better ways of treating cancer.

He also expressed satisfaction in the introduction of ADCETRIS to be part of the drug pipelines the company produces to support cancer treatment. Clay Siegall acquired a bachelor’s degree in Zoology from the Maryland University and a PhD in Genetics from Washington University. Prior to launching Seattle Genetics, he served at the National Institute of Health.